Adenovirus subversion of immune surveillance, apoptotic and growth regulatory pathways: a model for tumorigenesis

Janet Strath1, G E Blair

  • 1Institute of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK.

Insights

Adenovirus offers a new model to study tumor progression by examining how it evades immune surveillance and disrupts cell growth. Understanding these mechanisms could lead to new cancer therapies.

Area of Science:

  • Virology
  • Cancer Biology
  • Immunology

Background:

  • Adenovirus serves as a model system for investigating tumor progression.
  • Like other DNA tumor viruses, adenovirus evades immune surveillance.
  • Adenovirus disrupts cellular apoptotic and growth regulatory pathways.

Purpose of the Study:

  • To evaluate the roles of multiple factors in tumor progression using the adenovirus model.
  • To understand adenovirus's strategies for immune evasion.
  • To investigate the subversion of cellular networks by adenovirus.

Main Methods:

  • Utilizing the adenovirus system as a model.
  • Analyzing viral strategies for immune evasion.
  • Investigating cellular network perturbations.

Main Results:

  • Adenovirus employs strategies to evade immune surveillance.
  • Adenovirus perturbs cellular apoptotic and growth regulatory pathways.
  • Cellular network subversion by adenovirus is similar to that in tumor cells.

Conclusions:

  • The adenovirus system is a valuable model for studying tumor progression.
  • Further uncovering adenovirus's immune evasion and cellular interference mechanisms is crucial.
  • These findings have potential ramifications for designing novel cancer therapeutics.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...